Postoperative cognitive functions in patients with benign intracranial lesions

Stefanie Bette, Julia Ruhland, Benedikt Wiestler, Melanie Barz, Bernhard Meyer, Claus Zimmer, Yu‐Mi Ryang, Florian Ringel, Jens GemptScientific 2021 · DOI

Abstract

This study investigated the impact of surgical intervention on cognitive functions in 58 patients with benign intracranial lesions, including meningiomas, pituitary adenomas, and vascular malformations. Using an extensive neuropsychological battery, patients were assessed preoperatively ($t_0$), immediately post-surgery ($t_1$), and at a three-month follow-up ($t_2$). Results indicated that the majority of patients maintained or improved their cognitive performance in attention, memory, and executive functions at both postoperative time points. Factors such as age and tumor volume did not significantly influence cognitive outcomes in meningioma patients. These findings suggest that surgery for benign lesions does not typically result in cognitive deterioration.

Introduction

A primary concern for patients undergoing brain surgery is the risk of permanent cognitive impairment. While the cognitive effects of surgery for malignant neuroepithelial tumors (like gliomas) are well-documented, there is a lack of detailed longitudinal data regarding benign intracranial lesions. These lesions, though often slow-growing, can compress critical brain structures. This study addresses whether the surgical procedure itself causes more cognitive harm than the benefit derived from lesion removal.

Methods

The researchers conducted a prospective single-center study involving 58 patients (mean age 51.6 years). The cohort included various pathologies, primarily meningiomas (n=23), pituitary adenomas (n=8), and vascular lesions (n=9).

Cognitive assessment involved:

  • Screening: Mini-Mental Status Examination (MMSE).
  • Neuropsychological Battery: Specialized tests for attention (TAP), memory (WMS, VLMT, Rey-Osterrieth), and executive functions (TMT-B, Stroop, RWT).
  • Timeline: Assessments occurred preoperatively ($t_0$), immediately post-surgery ($t_1$, mean 7.6 days), and at follow-up ($t_2$, mean 99.5 days).
  • Controls: Mood (BDI-II) and pain (HDI) were monitored to ensure cognitive results were independent of emotional state or physical discomfort.

Results

The study found high rates of cognitive stability or improvement following surgery. Immediately post-surgery ($t_1$), more than 50% of patients showed stable or improved conditions in 12 out of 14 attention subtests, 11 out of 13 memory subtests, and 6 out of 9 executive function subtests.

Cognitive outcomes across domains at postoperative and follow-up stages.

By the three-month follow-up ($t_2$), the results were even more encouraging, with 100% of memory subtests (13/13) and executive function subtests (9/9) showing stability or improvement in the majority of the cohort. Basic cognitive screening (MMSE) scores remained stable, with a median score of 29.0 both pre- and postoperatively.

Discussion

The data suggests that the "surgical fog" often feared by patients is minimal and transient for benign lesions. Even within a week of surgery, cognitive scores remained largely stable, indicating that surgical trauma and anesthesia do not necessarily lead to lasting deficits in this population.

Individual patient trajectories for attention, memory, and executive function percentile ranks.

In a subgroup analysis of meningioma patients, the researchers found that traditional risk factors—such as age, tumor volume, and preoperative Karnofsky Performance Status (KPS)—did not significantly predict cognitive deterioration. This suggests that the potential for cognitive recovery or maintenance is high regardless of these baseline factors.

However, the study faced limitations, most notably a high dropout rate at the three-month follow-up (only 24 of 58 patients returned). This attrition bias could potentially skew results toward more positive outcomes if patients experiencing cognitive difficulties were less likely to return for testing.

Conclusion

In contrast to malignant brain tumors, surgery for benign intracranial lesions appears to be cognitively safe. The majority of patients experience stable or improved cognitive function across attention, memory, and executive domains. While further multi-center studies with higher patient retention are needed, these results provide significant reassurance to patients facing surgery for non-malignant brain lesions.

Summary updated

Abstract

The aim of this study was to assess pre- and postoperative cognitive functions in patients who underwent surgery for benign intracranial lesions. In total, 58 patients (21 men, 37 women, mean age 51.6 years [range 24-76 years]) with benign intracranial lesions (including benign tumors and vascular lesions) and neuralgia of the trigeminal nerve were included in this prospective study. Extensive cognitive testing was used to categorize attention, memory, and executive functions. Mood and pain were assessed preoperatively (t<sub>0</sub>, mean 3.7 days before surgery), immediately after surgery/during inpatient stay (t<sub>1</sub>, mean 7.6 days after surgery), and at first outpatient check-up (t<sub>2</sub>, mean 99.5 days after surgery). All 58 patients were tested at t<sub>0</sub> and t<sub>1</sub>, but at t<sub>2</sub> only 24 patients were available at t<sub>2</sub>. The data were categorized as improvement/stable condition or deterioration and shown as percentages. The pre- and postoperative values of BDI-II and mood were compared by the Wilcoxon test for paired samples. Binary logistic regression analyses were performed to identify parameters influencing cognition in the subgroup of meningioma patients. Immediately after surgery (t<sub>1</sub>), the percentage of patients with improvement/stable condition was > 50% in all categories in the majority of subtests (attention: 12/14 subtests, memory: 11/13 subtests, executive functions: 6/9 subtests). Similar results were shown at t<sub>2</sub>. Mood and pain did not change significantly after surgery. Factors like age, Karnofsky performance status, and tumor volume were not shown as significant influencing factors for cognitive functions in meningioma patients. The results of this study suggest that-in contrast to neuroepithelial tumors-cognitive functions do not deteriorate after surgery of benign intracranial lesions. Further studies are necessary to evaluate the results of this study.
BibTeX
@inproceedings{bette2021postoperative,
  author = {Stefanie Bette and Julia Ruhland and Benedikt Wiestler and Melanie Barz and Bernhard Meyer and Claus Zimmer and Yu‐Mi Ryang and Florian Ringel and Jens Gempt},
  title = {{Postoperative cognitive functions in patients with benign intracranial lesions}},
  booktitle = {Scientific},
  year = {2021},
  doi = {10.1038/s41598-021-88061-6},
}
Figure